Copyright
©The Author(s) 2017.
World J Hepatol. Dec 28, 2017; 9(36): 1322-1331
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1322
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1322
Variable | Multivariate analysis | |
Hazard ratio (95%CI) | P value | |
Macrovascular invasion | ||
No | 1 | 0.917 |
Yes | 1.066 (0.412-2.762) | |
Macrovascular invasion and/or extrahepatic spread | ||
No | 1 | 0.366 |
Yes | 1.552 (0.584-4.124) | |
Tumor size | ||
≤ 5 cm | 1 | 0.266 |
> 5 cm | 1.369 (0.786-2.382) | |
AFP (> 200 ng/mL vs ≤ 200 ng/mL) | ||
< 6 mo | 5.073 (2.159-11.916) | 0.00021 |
7-12 mo | 0.948 (0.275-3.267) | 0.932 |
> 12 mo | 1.698 (0.620-4.648) | 0.303 |
DC (Yes vs No) | ||
< 6 mo | 0.220 (0.075-0.650) | 0.096 |
7-12 mo | 0.463 (0.181-1.189) | 0.109 |
> 12 mo | 0.110 (0.038-0.314) | < 0.00011 |
- Citation: Ponziani FR, Spinelli I, Rinninella E, Cerrito L, Saviano A, Avolio AW, Basso M, Miele L, Riccardi L, Zocco MA, Annicchiarico BE, Garcovich M, Biolato M, Marrone G, De Gaetano AM, Iezzi R, Giuliante F, Vecchio FM, Agnes S, Addolorato G, Siciliano M, Rapaccini GL, Grieco A, Gasbarrini A, Pompili M. Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1322-1331
- URL: https://www.wjgnet.com/1948-5182/full/v9/i36/1322.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i36.1322